Trials / Completed
CompletedNCT00695825
Effects the Glycemic Index on Metabolic Risk Markers
Postprandial Effects of a Low vs. a High Glycemic Index Food Product on Metabolic Risk Markers in Lean and Obese Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Maastricht University Medical Center · Academic / Other
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Recent population studies have shown that the glycemic index (GI) of food products is positively associated with the risk of developing type 2 diabetes and cardiovascular disease (CVD). In the pathogenesis of type 2 diabetes and CVD, inflammatory processes play a pivotal role. In a previous intervention study (11 weeks), however, we found no effects of lower-GI vs. higher-GI diets on fasting inflammatory markers in subjects with increased risk of developing the metabolic syndrome. People, however, spent most of their time in the postprandial period. Therefore, there is a need to study the postprandial effects of low-GI vs. high-GI diets. In addition, it needs to be emphasized the GI is derived from studies in lean subjects, while especially overweight and obese people suffer from metabolic aberrations related to the development of type 2 diabetes and CVD. AIM: To investigate in obese subjects the postprandial effects of a low-GI vs. high-GI food product on metabolic risk markers. A second research objective is to compare these effects with those in lean subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Low GI+high GI | Consumption of low GI food product on day 1 Consumption of high GI food product on day 2 |
| DIETARY_SUPPLEMENT | High GI+low GI | Consumption of high GI food product on day 1 Consumption of low GI food product on day 2 |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2006-11-30
- Completion
- 2008-12-31
- First posted
- 2008-06-12
- Last updated
- 2018-04-26
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00695825. Inclusion in this directory is not an endorsement.